Physician profile
Heather Maune
NPI 1245556216
$1,997.26
in general payments reported to CMS, 2019-2025
19 companies · $48.44 in 2025
The $48.44 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.61 · 2020: $27.21 · 2021: $529 · 2022: $539 · 2023: $323 · 2024: $481 · 2025: $48.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $569.89 | 2021-2024 | |
| Aspira Women'S Health INC | $271.46 | 2021-2024 | Ova1 |
| Astellas Pharma US INC | $266.82 | 2019-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $149.07 | 2021-2023 | |
| Channel Medsystems, INC. | $146.27 | 2023 | |
| Organon LLC | $103.97 | 2021-2025 | Nexplanon, Jada System |
| Exeltis, USA INC. | $86.12 | 2021-2024 | Slynd |
| Biogen, INC. | $75.32 | 2024 | Zurzuvae |
| Coopersurgical, INC. | $72.54 | 2019-2024 | Endosee |
| Mylan Pharmaceuticals INC. | $39.99 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $37.10 | 2021-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Agile Therapeutics, INC. | $33.26 | 2021 | |
| Hologic Sales and Service, LLC | $32.24 | 2021-2025 | Myosure Tissue Removal Device |
| Ethicon US, LLC | $26.82 | 2021 | |
| Pfizer INC. | $23.38 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $19.89 | 2022 | |
| Mayne Pharma Commercial LLC | $19.65 | 2022 | |
| Olympus America INC. | $11.88 | 2022 | |
| Avion Pharmaceuticals | $11.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Maune listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.